David M Sniecinski

Title: David M Sniecinski: Innovator in Continuous Glucose Monitoring

Introduction

David M Sniecinski is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical technology, particularly in the area of continuous glucose monitoring systems. His innovative work aims to improve the lives of individuals managing diabetes.

Latest Patents

David M Sniecinski holds a patent for "Methods, systems, and devices for continuous glucose monitoring." This patent describes a continuous glucose monitoring system that utilizes electrode current (Isig) signals, Electrochemical Impedance Spectroscopy (EIS), and Vcntr values. The system is designed to optimize sensor glucose (SG) calculation, thereby reducing the need for blood glucose (BG) calibration requests from users. This advancement represents a significant step forward in diabetes management technology.

Career Highlights

David is currently employed at Medtronic Minimed, Inc., a leading company in diabetes management solutions. His work at Medtronic has allowed him to focus on developing innovative technologies that enhance patient care and improve health outcomes.

Collaborations

Throughout his career, David has collaborated with talented professionals, including Georgios Mallas and Andrea Varsavsky. These collaborations have contributed to the advancement of technologies in the medical field.

Conclusion

David M Sniecinski is a pioneering inventor whose work in continuous glucose monitoring systems is making a positive impact on diabetes management. His contributions to the field highlight the importance of innovation in healthcare technology.